Fig. 6
From: Myocyte enhancer factor 2D provides a cross-talk between chronic inflammation and lung cancer
Effects of signaling pathway inhibitors on LPS-induced MEF2D expression. a Western blotting analysis of MEF2D protein expression in A549 cells pretreated with ERK inhibitor PD98059 at doses of 10, 20 and 30 μM for 2 h and then stimulated with LPS (1 μg/ml) for 48 h; b Western blotting analysis of MEF2D protein expression in A549 cells pretreated with PI3K inhibitor LY290042 at doses of 10, 20 and 30 μM for 2 h and then stimulated with LPS (1 μg/ml) for 48 h. Data were presented as mean ± S.E.M and each group had at least six measurements. *p < 0.05, **p < 0.01, as compared with control group. +p < 0.05, as compared with LPS group